Your browser doesn't support javascript.
loading
Major alteration of Lung Microbiome and the Host Reaction in critically ill COVID-19 Patients with high viral load.
Bustos, Ingrid G; Wiscovitch-Russo, Rosana; Singh, Harinder; Sievers, Benjamín L; Matsuoka, Michele; Freire, Marcelo; Tan, Gene S; Cala, Mónica P; Guerrero, Jose L; Martin-Loeches, Ignacio; Gonzalez-Juarbe, Norberto; Reyes, Luis Felipe.
Affiliation
  • Bustos IG; Universidad de la Sabana.
  • Wiscovitch-Russo R; J Craig Venter Institute.
  • Singh H; J Craig Venter Institute.
  • Sievers BL; J Craig Venter Institute.
  • Matsuoka M; J Craig Venter Institute.
  • Freire M; J Craig Venter Institute.
  • Tan GS; J Craig Venter Institute.
  • Cala MP; MetCore- Metabolomics Core Facility, Universidad de Los Andes.
  • Guerrero JL; MetCore- Metabolomics Core Facility, Universidad de Los Andes.
  • Martin-Loeches I; St James's Hospital.
  • Gonzalez-Juarbe N; J Craig Venter Institute.
  • Reyes LF; Universidad de la Sabana.
Res Sq ; 2024 Mar 08.
Article de En | MEDLINE | ID: mdl-38496464
ABSTRACT

Background:

Patients with COVID-19 under invasive mechanical ventilation are at higher risk of developing ventilator-associated pneumonia (VAP), associated with increased healthcare costs, and unfavorable prognosis. The underlying mechanisms of this phenomenon have not been thoroughly dissected. Therefore, this study attempted to bridge this gap by performing a lung microbiota analysis and evaluating the host immune responses that could drive the development of VAP. Materials and

methods:

In this prospective cohort study, mechanically ventilated patients with confirmed SARS-CoV-2 infection were enrolled. Nasal swabs (NS), endotracheal aspirates (ETA), and blood samples were collected initially within 12 hours of intubation and again at 72 hours post-intubation. Plasma samples underwent cytokine and metabolomic analyses, while NS and ETA samples were sequenced for lung microbiome examination. The cohort was categorized based on the development of VAP. Data analysis was conducted using RStudio version 4.3.1.

Results:

In a study of 36 COVID-19 patients on mechanical ventilation, significant differences were found in the nasal and pulmonary microbiome, notably in Staphylococcus and Enterobacteriaceae, linked to VAP. Patients with VAP showed a higher SARS-CoV-2 viral load, elevated neutralizing antibodies, and reduced inflammatory cytokines, including IFN-δ, IL-1ß, IL-12p70, IL-18, IL-6, TNF-α, and CCL4. Metabolomic analysis revealed changes in 22 metabolites in non-VAP patients and 27 in VAP patients, highlighting D-Maltose-Lactose, Histidinyl-Glycine, and various phosphatidylcholines, indicating a metabolic predisposition to VAP.

Conclusions:

This study reveals a critical link between respiratory microbiome alterations and ventilator-associated pneumonia in COVID-19 patients, with elevated SARS-CoV-2 levels and metabolic changes, providing novel insights into the underlying mechanisms of VAP with potential management and prevention implications.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Res Sq Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Res Sq Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique